Clinical effect of Yiqi Fumai Injection combined with statins in the treatment of chronic heart failure complicated with atrial fibrillation
SU Haiyan1 WANG Kelong2
1.Department of Geriatrics, No.215 Hospital of Shaanxi Nuclear Industry, Shaanxi Province, Xianyang 712000, China;
2.Department of Cardiology, the First Affiliated Hospital of Xi′an Jiaotong University, Shaanxi Province, Xi′an 710000, China
Abstract:Objective To investigate the clinical effect of Yiqi Fumai Injection combined with statins in the treatment of chronic heart failure (CHF) with atrial fibrillation. Methods A total of 103 patients with CHF and atrial fibrillation who were admitted to the No.215 Hospital of Shaanxi Nuclear Industry from January 2016 to December 2017 were divided into the control group (n = 51) and the observation group (n = 52) by random number table method. The control group was given Rosuvastatin on the basis of conventional treatment, and the observation group was given Yiqi Fumai Injection on the basis of the control group. N-terminal B-brain natriuretic peptide (NT-proBNP) level, 6-min walking distance (6MWT), left ventricular end-diastolic diameter (LVEDd), left ventricular short-axis shortening rate (LVFS), left ventricle were observed before and after treatment. The recurrence rate of paroxysmal atrial fibrillation, the incidence of permanent atrial fibrillation and clinical efficacy were calculated. Results Compared with before treatment, the levels of 6MWT, LVFS and LVEF in the two groups were significantly increased after treatment (P < 0.05), and the observation group was significantly higher than the control group (P < 0.05). The levels of NT-proBNP and LVEDd in the two groups after treatment were significantly lower than those before treatment (P < 0.05), and the observation group was significantly lower than the control group (P < 0.05). The recurrence rate of atrial fibrillation and the rate of conversion to permanent atrial fibrillation in the observation group were significantly lower than those in the control group (P < 0.05). The clinical effective rate in the observation group was higher than that in the control group, and the difference was statistically significant (P < 0.05). Conclusion Yiqi Fumai Injection combined with Rosuvastatin can reduce NT-proBNP levels in patients with CHF complicated with atrial fibrillation, improve cardiac function, and effectively control ventricular rate, which is worthy of clinical promotion and application.
苏海燕1 王克隆2. 注射用益气复脉联合他汀类药物治疗慢性心力衰竭合并心房颤动的临床效果[J]. 中国医药导报, 2018, 15(35): 70-73.
SU Haiyan1 WANG Kelong2. Clinical effect of Yiqi Fumai Injection combined with statins in the treatment of chronic heart failure complicated with atrial fibrillation. 中国医药导报, 2018, 15(35): 70-73.